Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 19.34 USD 4.43% Market Closed
Market Cap: 2B USD

Wall Street
Price Targets

NRIX Price Targets Summary
Nurix Therapeutics Inc

Wall Street analysts forecast NRIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NRIX is 28.44 USD with a low forecast of 15.15 USD and a high forecast of 43.05 USD.

Lowest
Price Target
15.15 USD
22% Downside
Average
Price Target
28.44 USD
47% Upside
Highest
Price Target
43.05 USD
123% Upside
Nurix Therapeutics Inc Competitors:
Price Targets
EDT
Spectral Medical Inc
145% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
ALXO
ALX Oncology Holdings Inc
105% Upside
002252
Shanghai RAAS Blood Products Co Ltd
11% Upside
SBTX
SkinBioTherapeutics PLC
123% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
31% Upside
PRME
Prime Medicine Inc
78% Upside
INSM
Insmed Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Nurix Therapeutics Inc

For the last 5 years the compound annual growth rate for Nurix Therapeutics Inc's revenue is 12%. The projected CAGR for the next 4 years is 24%.

12%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nurix Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Nurix Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NRIX's stock price target?
Price Target
28.44 USD

According to Wall Street analysts, the average 1-year price target for NRIX is 28.44 USD with a low forecast of 15.15 USD and a high forecast of 43.05 USD.

What is Nurix Therapeutics Inc's Revenue forecast?
Projected CAGR
24%

For the last 5 years the compound annual growth rate for Nurix Therapeutics Inc's revenue is 12%. The projected CAGR for the next 4 years is 24%.

Back to Top